EGEN

About:

EGEN develops delivery systems for the manufacture of nucleic acid and anti-cancer drugs.

Website: http://www.egeninc.com

Description:

EGEN, Inc., is an Alabama-based specialty biopharmaceutical company developing safe and efficient delivery systems to be used to create products for treatment of human diseases. Their synthetic biocompatible delivery vehicles can be used to deliver therapeutic genes, inhibitory RNA (siRNA & shRNA) and small molecules. The delivery systems function by protecting the therapeutic cargo from degradation, promoting uptake by the target cells and facilitating intracellular trafficking.

Total Funding Amount:

$23.4M

Headquarters Location:

Huntsville, Alabama, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)egeninc.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2013-10-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai